Miscellaneous & Future Applications / Authorized User (from the RPT Curriculum Supplement Series)
Topics Covered:
Miscellaneous and Future Applications of Radiopharmaceutical Therapy – How To Become an Authorized User, Meta-iodobenzylguanidine, Rhenium Skin Cancer Therapy, Radiosynoviorthesis, Alpha Emitters, Other
- Michael Folkert, MD, PhD
For the presentation description, please see the Program tab.
This activity is available from July 19, 2024, through 11:59 p.m. Eastern time on July 4, 2026.
The content was originally presented and recorded on May 31, 2024 in the Beyond the Beam: A Radiation Oncology Curriculum for Radiopharmaceutical Therapy webinar series, a 15-hour in-depth curriculum supplement resource designed specifically for radiation oncology residents and practicing radiation oncologists who are planning or participating in a radiopharmaceutical therapy (RPT) clinical program. Learn more about the full series.
Target Audience
The activity is designed to meet the interests of radiation oncologists, radiation physicists, dosimetrists, radiation therapists, diagnostic radiologists, radiation biologists, medical oncologists and radiation oncology residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify novel applications of radiopharmaceutical therapies.
- Increase awareness of future directions in radiopharmaceutical therapies.
- Describe the process of becoming an authorized user.
Prior Authorization and Future Applications
This session reviews miscellaneous and future applications of radiopharmaceutical therapy, many of which are under development or in use outside of the U.S. Presenters discuss radiopharmaceutical applications such as meta-iodobenzylguanidine (MIBG) therapy, topical rhenium skin cancer therapy, radiosynoviorthesis, palliative radiopharmaceutical therapies, indications in hematologic malignancies, and the increasing role of alpha emitters in radiopharmaceutical therapies. Presenters also touch on how to become an authorized user for administration of radiopharmaceutical therapies.
- Michael Folkert, MD, PhD, is employed by Northwell Health. Dr. Folkert serves as Education Subcommittee Chair with the American Brachytherapy Society and is a radiation oncologist representative with the Advisory Committee on the Medical Uses of Isotopes.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Nonmember: $149
Member: $99
Member-in-training: $49
Student/Grad Student/PGY: $49
Postdoctoral Fellow: $49
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website until July 4, 2026, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.